CYP2C56P

Across TCGA pan-cancer cohorts, CYP2C56P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated CYP2C56P data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CYP2C56P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CYP2C56P expression acts as an unfavorable survival marker.

UCEC, THYM, and ESCA are the cancer types where CYP2C56P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.657	0.846	<.001	108	view →
THYM	OS	Tertile	All	0.186	0.931	<.001	45	view →
ESCA	DFS	Tertile	All	0.232	0.773	.006	18	view →
LIHC	OS	Tertile	All	0.258	0.773	.018	18	view →
STAD	DFS	Tertile	All	0.244	0.419	.040	9	view →
BRCA	OS	Tertile	All	0.820	0.924	.027	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

CYP2C56P–UCEC (DFS)

Open the UCEC breakdown →